Potential effects of cyclosporin A on coronary vasomotor function in young patients with systemic lupus erythematosus: comment on the article by Hirata et al.
Korkmaz
Cengiz
C
D000367:Age Factors; D018501:Antirheumatic Agents / Q000009:adverse effects*; D003327:Coronary Disease / Q000139:chemically induced*; D003331:Coronary Vessels / Q000187:drug effects*; D016572:Cyclosporine / Q000009:adverse effects*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*
D018501:Antirheumatic Agents; D016572:Cyclosporine